Vertex Pharmaceuticals United Kingdom — Total long-lived assets decreased by 5.1% to $167.60M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $176.60M to $167.60M.
vrtx_segment_united_kingdom_total_long_lived_assets| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $60.90M | $75.70M | $77.30M | $176.60M | $167.60M |
| QoQ Change | — | +24.3% | +2.1% | +128.5% | -5.1% |
| YoY Change | — | +24.3% | +2.1% | +128.5% | -5.1% |